神經鈣黏蛋白(NCAD)多克隆抗體
Polyclonal Antibody to N-cadherin (NCAD)
CDw325; CD325; CDHN; CDH2; Cadherin 2 Type 1; N-Cadherin
- 編號PAB481Hu02
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原RPB481Hu02-神經鈣黏蛋白(NCAD)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度0.39mg/mL
- 且適物種Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠)
- 應用WB; IHC
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 598¥ 1394¥ 1992¥ 4980¥ 19920
- 欲了解實際交易價格和更多情況，請與當?shù)亟涗N商聯(lián)系!
產品包裝(模擬)
產品包裝(模擬)
DAB staining on IHC-P; Samples: Human Glioma Tissue; Primary Ab: 30μg/ml Rabbit Anti-Human CDH2 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
DAB staining on IHC-P;
Samples: Human Breast cancer Tissue;
Primary Ab: 30μg/ml Rabbit Anti-Human CDH2 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
DAB staining on IHC-P;
Samples: Human Kidney Tissue;
Primary Ab: 30μg/ml Rabbit Anti-Human CDH2 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
Western Blot; Sample: Human Urine Primary Ab: 0.2μg/ml Rabbit Anti-Human NCAD Antibody Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
Western Blot; Samples: Lane1: Rat Heart lysate; Lane2: Mouse Cerebrum lysate; Lane3: Mouse Heart lysate;
Primary Ab: 0.2μg/ml Rabbit Anti-Human NCAD Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對NCAD的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別NCAD。
用法
Western blotting: 0.01-3μg/mL
Immunohistochemistry: 5-30μg/mL
Immunocytochemistry: 5-30μg/mL
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB481Hu02 | 神經鈣黏蛋白(NCAD)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB481Hu01 | 神經鈣黏蛋白(NCAD)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB481Hu01 | 神經鈣黏蛋白(NCAD)多克隆抗體 | WB |
| PAB481Hu02 | 神經鈣黏蛋白(NCAD)多克隆抗體 | WB; IHC |
| LAB481Hu71 | 神經鈣黏蛋白(NCAD)多克隆抗體(生物素標記) | WB |
| MAB481Hu22 | 神經鈣黏蛋白(NCAD)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB481Hu | 神經鈣黏蛋白(NCAD)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB481Hu | 神經鈣黏蛋白(NCAD)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Toxicology Letters | Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.[Pubmed: 23830989] |
| British journal of haematology | Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma.[Pubmed: 23438504] |
| JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | Elevated Cerebrospinal Fluid and Plasma N-Cadherin in Alzheimer Disease[Pubmed: 32296844] |
| Cell Biol Toxicol | ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer[33566221] |
| CELL BIOLOGY AND TOXICOLOGY | Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence[33758996] |
| Pharmacol Res | DOC2B is a Negative Regulator of Wnt/β-catenin Signaling Pathway in Cervical Cancer[Pubmed:35500882] |